Pfizer Inc. announced that David M. Denton will join the Company as Executive Vice President effective May 2, 2022. Mr. Denton will be a member of Pfizer's Executive Leadership Team reporting to Chairman and Chief Executive Officer, Albert Bourla. He joins Pfizer from Lowe's Companies Inc. where he served as CFO and Executive Vice President.

Mr. Denton succeeds Frank D'Amelio, CFO and Executive Vice President, who recently announced his intention to leave Pfizer after a notable 15-year career. Mr. D'Amelio has agreed to remain in place through a transition period.